PATRICIA
ASPICHUETA CELAA
PROFESORADO PLENO
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Clinic Barcelona (5)
2021
-
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Liver International, Vol. 41, Núm. 9, pp. 2076-2086
2020
-
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 216-225.e5
-
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25
2013
-
Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease
Hepatology, Vol. 57, Núm. 2, pp. 505-514
2012
-
Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1
Gastroenterology, Vol. 143, Núm. 3